
Cosimo Ducani
278 posts





We’re excited to announce the official launch of Tune Therapeutics and introduce our unique TEMPO platform. Our novel genetic tuning approach dials gene expression to healthy, functional levels – without breaking or rewriting DNA. Check us out here: bit.ly/tunelaunch


We’re proud to share that we filed a CTA to launch a clinical trial for NTLA-2002, an in vivo #CRISPR candidate targeting the root cause #HereditaryAmgiodema (HAE), a rare, life-threatening disorder. #NewEraofMedicine. intelliatx.com/in-vivo-therap…

Moligo Technologies has been awarded a grant from Vinnova. This will contribute to the technical development necessary to expand the company's production capacity and will accelerate the commercialisation of DNA molecules gene-based technologies. Thank you @vinnovase









Artificial intelligence has solved one of biology’s grand challenges: predicting how proteins curl up from a linear chain of amino acids into 3D shapes that allow them to carry out life’s tasks. fcld.ly/40ujroa

📣 Episode 3 of Season 2 of @PMedCast is out! Our new host Aradhana 🎙️ sat down with @CosimoDucani founder and CEO of @moligotech to talk about alternative and improved #enzymatic methods for #DNA synthesis. cutt.ly/ihiD0D4




